Polianta Ltd’s Globus Medical GMED Stock Holding History

Polianta Ltd’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66M	Buy	+21,000	New	+$1.78M	0.21%	73

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Polianta Ltd's GMED Position: Q2 2026 in Review

Polianta Ltd opened a new position in Globus Medical (GMED) in Q2 2026: 21,000 shares worth $1.66M. The stake represents 0.21% of the portfolio and ranks #73 among its holdings.

600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Polianta Ltd held 21,000 shares of Globus Medical worth $1.66M as of Q2 2026.
Globus Medical was a new Polianta Ltd position in Q2 2026.
Globus Medical made up 0.21% of Polianta Ltd's portfolio in Q2 2026, its #73 holding.
600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Polianta Ltd's 13F filing for Q2 2026, filed 8 Jul 2026.